Skip to main content
logo
Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.1570
+0.0090 (6.08%)
At close: Oct 9, 2026

Northwest Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
268358364822830663
Market Cap Growth
-28.35%-1.53%-55.72%-1.00%25.14%-47.13%
Enterprise Value
334444435881865686
Last Close Price
0.160.230.270.700.780.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----3.70
PS Ratio
123.23260.08263.35425.38493.23660.04
PB Ratio
-7.70-7.53-4.61-17.47-7.90-5.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
153.72322.41314.92455.93513.96682.10

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.62-1.36-0.85-0.97-0.25-0.31
Net Debt / Equity Ratio
-1.61-1.30-0.83-0.92-0.18-0.18
Net Debt / EBITDA Ratio
-1.17-1.07-1.01-0.80-0.29-0.43
Net Debt / FCF Ratio
-1.12-1.33-1.12-0.76-0.35-0.51
Asset Turnover
0.040.030.050.070.050.03
Quick Ratio
0.010.030.030.050.060.11
Current Ratio
0.040.060.060.090.080.13
Return on Assets (ROA)
-59.64%-69.33%-152.28%-117.23%-117.48%-90.17%
Return on Capital Employed (ROCE)
-1944.00%575.50%160.10%320.10%71.00%56.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-14.52%-16.79%-23.02%-7.62%-12.65%27.00%
FCF Yield
-18.59%-12.91%-15.95%-6.94%-6.71%-6.68%
Buyback Yield / Dilution
-16.62%-17.26%-10.99%-10.17%-0.79%-38.99%